Baxter announces global pharma R&D Centre in Ahmedabad

India Pharma Outlook Team | Tuesday, 18 October 2022

 India Pharma Outlook Team

Baxter Pharmaceuticals India Pvt Ltd announced the inauguration of a 20,500-square-foot, global R&D Centre in Ahmedabad. This centre will accelerate innovation in the generic and differentiated injectable pharmaceuticals space. The R&D centre will feature an array of sophisticated equipment and research labs that will focus on pharmaceutical product development and capabilities in therapeutic areas such as critical care, analgesic, renal, cardiovascular anesthesia, anti-infective and antipyretic.

It will support Baxter's global manufacturing facilities, including those in Ahmedabad, Germany, Ireland, Italy, and the United States, among others. According to the firm's statement the R&D centre will play an integral role in advancing pipeline, expanding products to new markets and innovating to continue responding to the needs of patients all over the world.

© 2024 India Pharma Outlook. All Rights Reserved.